ARTA
SBBP

A.R.T. Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

A.R.T. Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,387
Closed -$45K – 1205
2019
Q4 		$45K Buy
+21,387
New +$41K ﹤0.01% 1255
2018
Q4 		– Sell
-13,974
Closed -$67K – 1795
2018
Q3 		$67K Buy
+13,974
New +$71.5K ﹤0.01% 1304

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

A.R.T. Advisors's SBBP Position: Q1 2020 in Review

A.R.T. Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q1 2020, closing a stake of 21,387 shares — an estimated $45K sold.

A.R.T. Advisors first reported a position in SBBP in Q3 2018 and held it in 2 quarters. The position peaked at $67K in Q3 2018. 60 funds tracked by Wall St. Rank hold SBBP as of Q1 2020.

  • A.R.T. Advisors reported no remaining Strongbridge Biopharma plc. position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 21,387 Strongbridge Biopharma plc. shares in Q1 2020, an estimated $45K.
  • A.R.T. Advisors first reported a position in Strongbridge Biopharma plc. in Q3 2018 and held it in 2 quarters.
  • A.R.T. Advisors's Strongbridge Biopharma plc. position peaked at $67K in Q3 2018.
  • 60 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.